Transport mechanisms for the antidepressant citalopram in brain microvessel endothelium

Brain Research

Volumn 831, Issue 1-2, 1999, Pages 229-236

  Rochat, Bertrand ^a   Baumann, Pierre ^b   Audus, Kenneth L ^a  

^a UNIVERSITY OF KANSAS   (United States)

^b DEPT UNIV DE PSYCHIATRIE ADULTE   (Switzerland)

Author keywords

Antidepressant; Blood brain barrier; Bovine brain microvessel endothelial cell; Carrier; Enantiomer; P glycoprotein; Selective serotonin reuptake inhibitor; Stereoselectivity; Transport

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING); CITALOPRAM; CYCLOSPORIN A; CYTOCHROME P450 ISOENZYME; DOPAMINE; DRUG CARRIER; GLYCOPROTEIN P; RHODAMINE 123; SEROTONIN; SEROTONIN UPTAKE INHIBITOR; TRYPTOPHAN;

ANIMAL CELL; ARTICLE; BLOOD BRAIN BARRIER; CATTLE; CELL MEMBRANE PERMEABILITY; CONTROLLED STUDY; DRUG TRANSPORT; ENZYME INHIBITION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MICROVASCULATURE; NONHUMAN; PRIORITY JOURNAL; STEREOCHEMISTRY; TEMPERATURE DEPENDENCE; VASCULAR ENDOTHELIUM;

ANIMALS; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; BIOLOGICAL TRANSPORT; BLOOD-BRAIN BARRIER; CATTLE; CELLS, CULTURED; CITALOPRAM; DOPAMINE; ENDOTHELIUM, VASCULAR; MONOAMINE OXIDASE INHIBITORS; SEROTONIN; SEROTONIN UPTAKE INHIBITORS; STEREOISOMERISM; TRYPTOPHAN;

EID: 0033549263     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(99)01461-4     Document Type: Article

References (36)

1. K.L. Audus, L. Ng, W. Wang, R.T. Borchardt, Brain microvessel endothelial cell culture systems, Pharm. Biotechnol. 8 (1996) 239-258.
2. K.L. Audus, P.J. Chikhale, D.W. Miller, S.E. Thompson, R.T. Borchardt, Brain uptake of drugs: the influence of chemicals and biological factors, Adv. Drug Res. 23 (1992) 1-64.
3. A. Baranczyk-Kuzma, K.L. Audus, R.T. Borchardt, Catecholamine-metabolizing enzymes of bovine brain microvessel endothelial cell monolayers, J. Neurochem. 46 (1986) 1956-1960.
4. M. Bauer, C. Megret, A. Lamure, C. Lacabanne, M.-J. Fauran-Clavel, Differential scanning calorimetry study of the interaction of antidepressant drugs, noradrenaline, and 5-hydroxytryptamine with a membrane model, J. Pharm. Sci. 79 (1990) 897-901.
5. P. Baumann, B. Rochat, Comparative pharmacokinetics of selective serotonin reuptake inhibitors: a look behind the mirror, Int. Clin. Psychopharmacol. 10 (1995) 15-21, Suppl 1.
6. L. Bertilsson, K. Otani, M.L. Dahl, C. Nordin, A. Aberg-Wistedt, Stereoselective efflux of (E)-10-hydroxynortriptyline enantiomers from the cerebrospinal fluid of depressed patients, Pharmacol. Toxicol. 68 (1991) 100-103.
7. R. Blakely, H. Berson, R. Fremeau, M. Caron, M. Peek, H. Prince, C. Bradley, Cloning and expression of a functional serotonin transporter from rat brain, Nature 354 (1991) 66-70.
8. G. Bondolfi, C. Chautems, B. Rochat, G. Bertschy, P. Baumann, Non-response to citalopram in depressive patients: pharmacokinetic and clinical consequences of a fluvoxamine augmentation, Psychopharmacology 128 (1996) 421-425.
9. T. Breidert, F. Spitzenberger, D. Grundemann, E. Schomig, Catecholamine transport by the organic cation transporter type 1, Br. J. Pharmacol. 125 (1998) 218-224.
10. 3H]paroxetine to caudate nucleus and microvessels from porcine brain, NeuroReport 7 (1996) 1405-1408.
11. 3H]imipramine indicates the presence of a specific serotonin transport system on endothelial cells of porcine brain, Neurosci. Lett. 194 (1995) 21-24.
12. P. Conus, G. Bondolfi, C.B. Eap, F. Macciardi, P. Baumann, Pharmacokinetic fluvoxamine-clomipramine interaction with favorable therapeutic consequences in therapy-resistant depressive patient, Pharmacopsychiatry 29 (1996) 108-110.
13. M. Fontaine, W.F. Elmquist, D.W. Miller, Use of rhodamine 123 to examine the functional activity of P-glycoprotein in primary cultured brain microvessel endothelial cell monolayers, Life Sci. 59 (1996) 1521-1531.
14. R.W. Fuller, H.D. Snoddy, Drug concentrations in mouse brain at pharmacologically active doses of fluoxetine enantiomers, Biochem. Pharmacol. 45 (1993) 2355-2358.
15. L.S. Gan, M.A. Moseley, B. Khosla, P.F. Augustijns, T.P. Bradshaw, R.W. Hendren, D.R. Thakker, CYP3A-like cytochrome P450-mediated metabolism and polarized efflux of cyclosporin A in Caco-2 cells, Drug Metab. Dispos. 24 (1996) 344-349.
16. J.F. Ghersi-Egea, B. Lehiinger-Muller, R. Cecchelli, J.D. Fenstermacher, Blood-brain interfaces: relevance to cerebral drug metabolism, Toxicol. Lett. 82-83 (1995) 645-653.
17. J. Hyttel, Citalopram - Pharmacological profile of specific serotonin uptake inhibitor with antidepressant activity, Prog. Neuropsychopharmacol. Biol. Psychiatry 6 (1982) 277-295.
18. J. Hyttel, K.P. Bogeso, J. Perregaard, C. Sanchez, The pharmacological effect of citalopram residues in the (S)-(+)-enantiomer, J. Neural Transm. 88 (1992) 157-160.
19. F. Joo, Endothelial cells of the brain and other organ systems: some similarities and differences, Prog. Neurobiol. 48 (1996) 255-273.
20. F. Joo, The blood, brain barrier in vitro: the second decade, Neurochem. Int. 23 (1993) 499-521.
21. H. Koepsell, Organic cation transporters in intestine, kidney, liver, and brain, Annu. Rev. Physiol. 60 (1998) 243-260.
22. R. Lane, D. Baldwin, Selective serotonin reuptake inhibitor, induced serotonin syndrome: review, J. Clin. Psychopharmacol. 17 (1997) 208-221.
23. C.L. Martet, J.B. Mackic, J.D. Adams Jr., J.G. McComb, M.H. Weiss, B.V. Zlokovic, Transport of dopamine at the blood-brain barrier of the guinea pig: inhibition by psychotropic drugs and nicotine, Pharm. Res. 13 (1996) 290-295.
24. D.W. Miller, H.Y. Han, D. Carrney, Is the probenecid-sensitive transporter in the blood-brain barrier multidrug resistance associated protein (MRP)?, Pharm. Res. 14 (1997) S332.
25. A. Minn, J.F. Ghersi-Egea, R. Perrin, B. Leininger, G. Siest, Drug metabolizing enzymes in the brain and cerebral microvessels, Brain Res. 16 (1991) 65-82.
26. S. Noble, P. Benfield, Citalopram - A review of its pharmacology, clinical efficacy and tolerability in the treatment of depression, CNS Drugs 8 (1997) 410-431.
27. B. Rochat, M. Amey, M. Gillet, U.A. Meyer, P. Baumann, Identification of three cytochrome P450 isozymes involved in N-demethylation of citalopram enantiomers in human liver microsomes, Pharmacogenetics 7 (1997) 1-10.
28. B. Rochat, M. Amey, H. Van Gelderen, B. Testa, P. Baumann, Determination of the enantiomers of citalopram its demethylated and propionic acid metabolites in human plasma by chiral HPLC, Chirality 7 (1995) 389-395.
29. B. Rochat, M. Kosel, G. Boss, B. Testa, M. Gillet, P. Baumann, Stereoselective biotransformation of the selective serotonin re-uptake inhibitor citalopram and its demethylated metabolites by monoamine oxidases in human liver, Biochem. Pharmacol. 56 (1998) 15-23.
30. W. Sadee, Membrane transporters: gateways to the future, Pharm. News 4 (1997) 8-11.
31. R. Sandstrom, A. Karlsson, H. Lennernas, The absence of stereoselective P-glycoprotein-mediated transport of R/S-verapamil across the rat jejunum, J. Pharm. Pharmacol. 50 (1998) 729-735.
32. G.K. Scriba, R.T. Borchardt, Metabolism of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) by bovine brain microvessel endothelial cells, Brain Res. 501 (1989) 175-178.
33. A. Seelig, A general pattern for substrate recognition by P-glycoprotein, Eur. J. Biochem. 251 (1998) 252-261.
34. J. Sidhu, M. Priskorn, M. Poulsen, A. Segonzac, G. Grollier, F. Larsen, Steady-state pharmacokinetics of the enantiomers of citalopram and its metabolites in humans, Chirality 9 (1997) 686-692.
35. C. Sur, H. Betz, P. Schloss, Distinct effects of imipramine on 5-hydroxytryptamine uptake mediated by the recombinant rat serotonin transporter SERT1, J. Neurochem. 70 (1998) 2545-2553.
36. J. Van Asperen, U. Mayer, O. Van Tellingen, J.H. Beijnen, The functional role of P-glycoprotein in the blood-brain barrier, J. Pharm. Sci. 86 (1997) 881-884.